Lafutidine Capsules

Lafutidine is an H2 receptor blocker. It can sustainably inhibit gastric acid secretion and act on the capsaicin-sensitive afferent neurons in the gastric mucosa to protect the gastric mucosa, promote mucosal repair, increase gastric mucosal blood flow, and increase gastric mucus secretion.

The main ingredient of this product is lafutidine, and its chemical name is: (±)-2-[2-(furanmethyl)sulfinyl]-N-[4-[4-(piperidinylmethyl)-2-pyridinyl]oxy-(Z)-2-butenyl]acetamide.

This product is a capsule, and the contents are white or off-white powder.

Used for gastric ulcer and duodenal ulcer.

For adults, take orally 10 mg (1 tablet) twice a day, after meals or before bedtime.

Not yet clear.

This product is contraindicated for use by persons known to be allergic to this product or its ingredients.

Precautions for children: Not yet clear. Precautions for pregnancy and lactation: Not yet clear. Precautions for the elderly: Not yet clear.

Other H2 receptor blockers can bind to cytochrome P450, thereby reducing the activity of liver microsomal drug-metabolizing enzymes. Therefore, caution should be exercised when this product is used in combination with warfarin, phenytoin sodium, theophylline, phenobarbital, diazepam or propranolol and cimetidine.

Keep in a light-proof and sealed place. The validity period is tentatively 30 months.

5mg

24 months

SPH Qingdao Growful Pharmaceutical Co., Ltd.

• Founded in:

  1994-06-30

• Address:

  No. 18, Songhuajiang Road, Qingdao Economic and Technological Development Zone

• Tax NO.:

  91370200264584097H

• Registered Funds:

  93 million yuan

• Website:

  Log in to view

• Email:

  Log in to view